XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities:    
Net income (loss) $ (187,847) $ 285,030
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Investment income (18,030) (121,804)
Depreciation and amortization 1,498 19,732
Equity-based compensation 13,380 59,756
Net realized and unrealized (gain) loss from consolidated funds’ investments 320,388 (8,931)
Accretion of original issue and market discount of consolidated funds’ investments, net (17,645) (4,305)
Income distributions from corporate investments in funds and companies 23,334 123,911
Other non-cash items 104 3,295
Cash flows due to changes in operating assets and liabilities:    
Net cash used in operating activities (775,656) (2,796,179)
Cash flows from investing activities:    
Purchases of U.S. Treasury and other securities (35,731) (602,600)
Proceeds from maturities and sales of U.S. Treasury and other securities 35,631 1,124,951
Corporate investments in funds and companies (196,949) (254,478)
Distributions and proceeds from corporate investments in funds and companies 229,543 373,916
Purchases of fixed assets (315) (6,366)
Net cash provided by investing activities 32,179 635,423
Cash flows from financing activities:    
Net cash provided by financing activities 1,062,941 2,415,944
Effect of exchange rate changes on cash (8,799) (12,078)
Net increase in cash and cash-equivalents 310,665 243,110
Deconsolidation of funds (101,148) (102,839)
Cash and cash-equivalents, beginning balance 841,793 831,727
Cash and cash-equivalents, ending balance 1,051,310 971,998
Total cash and cash-equivalents 1,051,310 971,998
Oaktree Capital Group Excluding Consolidated Funds    
Cash flows due to changes in operating assets and liabilities:    
Decrease in deferred tax assets 6 0
(Increase) decrease in other assets 787 (3,883)
Decrease in net due from affiliates 57,631 281,791
Decrease in accrued compensation expense (34,983) (191,859)
Increase (decrease) in accounts payable, accrued expenses and other liabilities (3,894) 65,325
Cash flows from financing activities:    
Capital contributions 56,023 0
Repurchase and cancellation of units 0 (12,191)
Distributions to Class A unitholders (69,797) (436,494)
Distributions to OCGH unitholders (43,678) (358,455)
Distributions to preferred unitholders (20,487) (20,487)
Distributions to non-controlling interests 0 (3,421)
Cash and cash-equivalents, ending balance 204,522 356,431
Total cash and cash-equivalents 204,522 356,431
Consolidated Funds    
Cash flows due to changes in operating assets and liabilities:    
Increase (decrease) in accounts payable, accrued expenses and other liabilities (14,681) 26,111
(Increase) decrease in dividends and interest receivable 23,967 (8,437)
(Increase) decrease in due from brokers (8,221) 11,476
Increase in receivables for securities sold (28,354) (27,609)
Increase in other assets (6,426) (7,074)
Increase (decrease) in payables for securities purchased (17,003) 123,853
Purchases of securities (3,030,232) (5,571,689)
Proceeds from maturities and sales of securities 2,150,565 2,149,132
Cash flows from financing activities:    
Distributions to non-controlling interests (217,851) (107,071)
Contributions from non-controlling interests 863,893 519,684
Proceeds from debt obligations issued by CLOs 1,030,422 3,892,380
Payment of debt issuance costs (2,780) (3,070)
Repayment on debt obligations issued by CLOs (559,694) (1,188,452)
Borrowings on credit facilities 75,380 505,521
Repayments on credit facilities (48,490) (372,000)
Cash and cash-equivalents, ending balance 846,788 615,567
Total cash and cash-equivalents $ 846,788 $ 615,567